Cell
Volume 78, Issue 1, 15 July 1994, Pages 35-43
Journal home page for Cell

RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

https://doi.org/10.1016/0092-8674(94)90570-3Get rights and content

Abstract

The immunosuppressants rapamycin and FK506 bind to the same intracellular protein, the immunophilin FKBP12. The FKBP12-FK506 complex interacts with and inhibits the Ca2+-activated protein phosphatase calcineurin. The target of the FKBP12-rapamycin complex has not yet been identified. We report that a protein complex containing 245 kDa and 35 kDa components, designated rapamycin and FKBP12 targets 1 and 2 (RAFT1 and RAFT2), interacts with FKBP12 in a rapamycin-dependent manner. Sequences (330 amino acids total) of tryptic peptides derived from the 245 kDa RAFT1 reveal striking homologies to the yeast TOR gene products, which were originally identified by mutations that confer rapamycin resistance in yeast. A RAFT1 cDNA was obtained and found to encode a 289 kDa protein (2549 amino acids) that is 43% and 39% identical to TOR2 and TOR1, respectively. We propose that RAFT1 is the direct target of FKBP12-rapamycin and a mammalian homolog of the TOR proteins.

References (55)

  • Y.J. Jin et al.

    Molecular cloning of a 25 KDa high affinity rapamycin binding protein, FKBP25

    J. Biol. Chem.

    (1992)
  • J. Kunz et al.

    Cyclosporin A, FK506, and rapamycin: more than just immunosuppression

    Trends Biochem. Sci.

    (1993)
  • J. Kunz et al.

    Target of rapamycin in yeast, TOR2, is an essential phosphatidyl kinase homolog required for G1 progression

    Cell

    (1993)
  • J. Liu

    FK506 and ciclosporin: molecular probes for studying intracellular signal transduction

    Trends Pharmacol. Sci.

    (1993)
  • J. Liu et al.

    Calcineurin is a common target of the cyclophilin-cyclosporin A and FKBP-FK506 complexes

    Cell

    (1991)
  • W.G. Morice et al.

    Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes

    J. Biol. Chem.

    (1993)
  • D.B. Smith et al.

    Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

    Gene

    (1988)
  • P. Tempst et al.

    Examination of automated polypeptide sequencing using standard phenyl isothiocyanate reagent and subpicomole high performance liquid chromatographic analysis

    Anal. Biochem.

    (1989)
  • A.P. Timerman et al.

    The calcium release channel of sarcoplasmic reticulum is modulated by FK506-binding protein

    J. Biol. Chem.

    (1993)
  • T. Balla et al.

    Inositol polyphosphates are not increased by overexpression of Ins(1,4,5)P3 3-kinase but show cell-cycle dependent changes in growth factor-stimulated fibroblasts

    Mol. Biol. Cell

    (1994)
  • B.E. Bierer et al.

    Two distinct signal transduction pathways in T lymphocytes are inhibited by the complexes formed between an immunophilin and either FK506 or rapamycin

    Proc. Natl. Acad. Sci. USA

    (1990)
  • B.E. Bierer et al.

    Probing immunosuppressant action with a nonnatural immunophilin ligand

    Nature

    (1990)
  • M.A. Blanar et al.

    Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos

    Nature

    (1992)
  • J.F. Borel

    Ciclosporin

    Progr. Allergy

    (1986)
  • R. Cafferkey et al.

    Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity

    Mol. Cell. Biol.

    (1993)
  • C. Chung et al.

    Rapamycin-FKBP specifically blocks growth-dependent activation and signaling by the 70 kd S6 protein kinases

    Cell

    (1992)
  • F.J. Dumont et al.

    The immunosuppressive macrolides FK506 and rapamycin act as reciprocal antagonists in murine T cells

    J. Immunol.

    (1990)
  • Cited by (0)

    View full text